Search results for "Highlights"

Results 1 - 10 of about 191 for "Highlights".
Sort by: Relevance | Newest | Oldest

NASH management conflicts with guidelines in real-world setting, study finds

Researchers sought to learn how patient characteristics vary by stages of liver scarring and how U.S. physicians manage nonalcoholic steatohepatitis (NASH).
26 May 2023


ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.

Rise in liver disease deaths not fully explained by metabolic syndrome or alcohol use

An analysis of the prevalence of metabolic syndrome and alcohol use in the U.S. between 1999 and 2018 found that while the proportion of patients with metabolic syndrome and nonheavy alcohol use grew the most, liver disease increased the most among those who drank heavily.
26 May 2023

Guidance issued on pharmacologic treatment of chronic idiopathic constipation

The joint clinical practice guideline from the American Gastroenterological Association and the American College of Gastroenterology reviewed evidence on fiber, osmotic laxatives, stimulant laxatives, secretagogues, and a serotonin type 4 agonist.
26 May 2023

New practice guidance released for NAFLD

The recommendations from the American Association for the Study of Liver Diseases cover the clinical assessment and management of patients with nonalcoholic fatty liver disease (NAFLD).
24 Mar 2023

Review finds only two efficacious medications to treat gastroparesis

Clebopride ranked first for efficacy, followed by domperidone, and no other drug was superior to placebo for improving symptoms of gastroparesis, according to a recent meta-analysis.
27 Jan 2023

Elimination diets effective for patients with eosinophilic esophagitis

A systematic review and meta-analysis of 34 studies found that a six-food elimination diet was not significantly better than less restrictive dietary regimens for histological remission and clinical symptom improvement.
24 Feb 2023

ACG updates its guideline on acute lower GI bleeding

The American College of Gastroenterology (ACG) now recommends risk stratification to identify patients who can be discharged early and advises on the use of anticoagulant reversal agents, among other changes.
24 Mar 2023

Mesalamine moderately useful in IBS, but confidence in evidence is low

The authors of a recent meta-analysis wrote that guidelines for irritable bowel syndrome (IBS) management should not recommend the drug until adequately powered studies are available.
24 Mar 2023

GI bleeding risks with warfarin and DOACs compared

Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
26 Aug 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next